Swiss Gov’t Won’t Go To Bat For Novartis

2 Comments

out-of-luck.jpgThe drugmaker won’t get a lift from Bern. The Swiss government apparently has decided not to pursue the allegation that India’s patent law isn’t compatible with the Trade-Related Aspects of Intellectual Property Rights (TRIPS) agreement to the World Trade Organization’s dispute settlement board, according to The Business Standard.

“The Swiss government never gets involved in any judicial pronouncements of other countries. We accept any case which is settled in India. It is a normal litigation in which one party happens to be a company while other is a country,” Doris Leuthard, Federal Councilor, Department of Economic Affairs of the Swiss Confederation tells the paper.

“We must have a reliable TRIPS system, and the one in India is good enough,” says Leuthard, who was in New Delhi to sign an Memorandum of Understanding on cooperation in international property rights with India.

Her comments came after the Madras High Court yesterday rejected a Novartis petition questioning the validity of the Indian Patents Act, which restricts patenting of minor improvements of known molecules. The drugmaker was championing its Gleevec cancer med, but the court advised Novartis to approach the dispute settlement forum of WTO on TRIPS compliance for which the Swiss company would have to approach its government.

However, Leuthard also says the impact of the verdict on prospective Swiss investors in India remains to be seen. “I do not know how Swiss companies will react to it. May be, they will have a closer look at the verdict. Some of them may find that investing in India may not be attractive,” she says.

According to Commerce Minister Kamal Nath, the Indian Patents Law is compatible with TRIPS and there have been no complaints against it in the international forum. “It has been two years since the Indian Patents Act has been passed, and no country has filed any complaint in the WTO. This Act is compliant with TRIPS,” says Nath, who was at the meeting in New Delhi.

The memorandum between India and Switzerland is expected to lead to the formation of a committee, which will facilitate exchange of experience by both the countries on creating awareness as well as protection of traditional knowledge.

Jump to comments

Share

Comments

  1. Hmm, how novel, the Swiss are being, well Swiss…

    Actually, in this case I couldn’t agree more!

    Congratulations to the patients…

    Power to the people !

  2. Bravo to India and Bravo to Swiss government. In many comments we saw words that described the Swiss as really nice caring and decent people as is their government. Unfortunately Novartis has parted ways with the Swiss tradition and decency since the big merger some 11 years ago. They picked the low road for doing business as mainly all businesses do but pharam did not till recently. No more ETHICAL PHARMACEUTICAL in big pharma business. That died with the mergomania that raged for over 15 years now.
    I know what I will do today. Go out and buy another Swiss made watch and add it to my collection. They are timeless as the Swiss but not as Swiss pharma companies. What a shame.

Subscribe

RSS Feed

Comments feed for this post only.

Tags

, , , ,

Clear

Clear

© 2007- 2008 Newark Morning Ledger Co.  All Rights Reserved.

Thanks for trying out the new Pharmalot printing tools. If you're got any suggestions for how we can help you print better, please let us know by clicking on the contact link at http://www.pharmalot.com/